Stockscreener 앱 받기
28.76
5.16%
1.41
시간 외 거래:
28.71
-0.05
-0.17%
전일 마감가:
$27.35
열려 있는:
$27.71
하루 거래량:
105.25K
Relative Volume:
0.28
시가총액:
$341.91M
수익:
$47.11M
순이익/손실:
$15.64M
주가수익비율:
38.58
EPS:
0.7455
순현금흐름:
$-15.89M
1주 성능:
+7.07%
1개월 성능:
+17.87%
6개월 성능:
-21.63%
1년 성능:
+37.61%
1일 변동 폭
$27.58
$29.31
1주일 범위
$25.72
$30.12
52주 변동 폭
$18.35
$39.92
Xoma Royalty Corp Stock (XOMA) Company Profile
명칭
Xoma Royalty Corp
전화
510-204-7239
주소
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
28.76 | 325.15M | 47.11M | 15.64M | -15.89M | 0.7455 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-17 | 개시 | The Benchmark Company | Buy |
| 2024-04-29 | 개시 | Leerink Partners | Outperform |
| 2021-09-07 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2021-06-29 | 개시 | Aegis Capital | Buy |
| 2021-01-19 | 재확인 | H.C. Wainwright | Buy |
| 2018-01-18 | 재확인 | H.C. Wainwright | Buy |
| 2017-10-17 | 재개 | H.C. Wainwright | Buy |
| 2017-09-05 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2017-06-12 | 개시 | H.C. Wainwright | Buy |
| 2016-11-14 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2016-03-11 | 재확인 | Wedbush | Outperform |
| 2015-07-23 | 다운그레이드 | Jefferies | Buy → Hold |
| 2015-07-22 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2015-07-22 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2014-10-10 | 재개 | ROTH Capital | Buy |
| 2014-04-29 | 업그레이드 | MLV & Co | Hold → Buy |
| 2014-03-11 | 다운그레이드 | MLV & Co | Buy → Hold |
| 2014-03-05 | 재확인 | Ladenburg Thalmann | Buy |
| 2013-10-31 | 재확인 | MLV & Co | Buy |
| 2013-05-09 | 재확인 | Ladenburg Thalmann | Buy |
| 2012-05-14 | 개시 | Cowen & Co | Outperform |
| 2011-03-31 | 재확인 | MLV Capital | Buy |
| 2011-03-23 | 재확인 | RBC Capital Mkts | Outperform |
| 2011-01-06 | 재확인 | Ladenburg Thalmann | Buy |
| 2011-01-04 | 재확인 | Wedbush | Outperform |
모두보기
Xoma Royalty Corp 주식(XOMA)의 최신 뉴스
XOMA Royalty (NASDAQ:XOMA) Issues Quarterly Earnings Results, Beats Expectations By $0.16 EPS - MarketBeat
XOMA Royalty Corp 2025 Annual Report: Financials, Nasdaq Listings, and Key Agreements (10-K Filing) - Minichart
XOMA Q1 2026 slides: royalty receipts surge 68%, portfolio tops 120 assets - Investing.com Canada
XOMA Corp8.375% DP PFD B declares $0.5234 dividend - MSN
XOMA Royalty Q4 Earnings Call Highlights - Yahoo Finance
XOMA Royalty Declares Quarterly Preferred Stock Dividends - The Manila Times
$0.54 and $0.52 payouts: XOMA preferred dividends due April 15 - Stock Titan
Xoma Royalty 2025 10-K: $52.1M Revenue, $31.7M Net Income - TradingView
XOMA Royalty (NASDAQ: XOMA) grows 2025 royalty cash flow and expands deals - Stock Titan
XOMA Royalty Reports Strong 2025 Financial Results, Expands Portfolio and Anticipates Key 2026 Pipeline Events - Minichart
XOMA shares climb after Q4 results top forecasts on strong royalty income - MSN
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock By Investing.com - Investing.com Canada
Earnings call transcript: XOMA Q4 2025 earnings beat boosts stock - Investing.com
XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead - Benzinga
XOMA shares jump 7% as strong royalty receipts drive Q4 earnings, revenue beat - Investing.com
XOMA Royalty (NASDAQ: XOMA) swings to 2025 profit as royalties and milestones surge - Stock Titan
XOMA Royalty Corporation Reports Strong Financial Results and Strategic Developments for Full Year 2025 - Quiver Quantitative
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements - Stock Titan
XOMA (XOMA) CEO granted 126,813 performance units and new RSUs - Stock Titan
XOMA (XOMA) CIO receives stock, PSU grants and updates holdings - Stock Titan
CFO at XOMA (XOMA) receives 138,462 PSUs and 90,000 RSUs - Stock Titan
Equity awards for XOMA (XOMA) Chief Legal Officer include RSUs and PSUs - Stock Titan
Aug Retail: Why is XOMA Royalty Corporation stock going downQuarterly Market Summary & Reliable Price Breakout Alerts - baoquankhu1.vn
XOMA Royalty Corporation EFFE Depositary Shares Representing 1/1000th Perpetual Preferred Stock (XOMAO.US) will release its earnings report before the market opens on March 18. - 富途牛牛
FMR LLC's Strategic Acquisition of XOMA Royalty Corp Shares - GuruFocus
XOMA Royalty (NASDAQ:XOMA) Downgraded to Strong Sell Rating by Zacks Research - MarketBeat
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 - The Manila Times
XOMA Royalty sets March 18 webcast on 2025 financial results - Stock Titan
XOMA Royalty (XOMA) to Release Earnings on Monday - MarketBeat
XOMA|XOMA Royalty Corp|Price:25.980|Chg%:-0.33 - TradingKey
FMR LLC holds 10.2% of XOMA Royalty (XOMA) after Schedule 13G/A amendment - Stock Titan
Layoff Watch: Why is XOMA Royalty Corporation stock going downJuly 2025 WrapUp & Precise Swing Trade Alerts - baoquankhu1.vn
XOMA Royalty Corporation (NASDAQ:XOMA) Short Interest Update - MarketBeat
XOMA (NASDAQ: XOMA) details 2025 royalty cash, buybacks and litigation costs - Stock Titan
LVTX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
XOMA Royalty Corporation (NASDAQ:XOMA) Receives $60.60 Average Price Target from Brokerages - Defense World
What Analysts Are Saying About XOMA Royalty Stock - Sahm
Leerink raises Xoma stock price target on royalty outlook - Investing.com
XOMA Royalty Corporation (NASDAQ:XOMA) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
MURAMural Oncology PLC Latest Stock News & Market Updates - Stock Titan
XOMA Royalty to Present at Investor Conferences in March - 富途牛牛
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right - Intellectia AI
Biotech royalty player XOMA lines up March investor talks - Stock Titan
Short Interest in XOMA Royalty Corporation (NASDAQ:XOMA) Grows By 27.4% - MarketBeat
What drives XOMA Royalty Corporation’s stock priceJuly 2025 Gainers & Smart Swing Trading Alerts - mfd.ru
XOMA Royalty (NASDAQ:XOMA) Upgraded by TD Cowen to "Hold" Rating - MarketBeat
Why XOMA Royalty Corporation stock is rated strong buyJuly 2025 Outlook & Verified Swing Trading Watchlists - mfd.ru
XOMA Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Xoma stock rating reinstated as Hold by TD Cowen after Generation Bio acquisition - Investing.com South Africa
Buyback Watch: What drives XOMA Royalty Corporations stock priceJuly 2025 Market Mood & Risk Controlled Stock Alerts - baoquankhu1.vn
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
Xoma Royalty Corp (XOMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):